Oxygen deprivation (hypoxia) in non–small cell lung cancer (NSCLC) is an important factor
in treatment resistance and poor survival. Hypoxia is an attractive therapeutic target, …

Owing to advances in radiotherapy, the physical properties of radiation can be optimized to
enable individualized treatment; however, optimization is rarely based on biological …

Combretastatin A4 phosphate (CA4P) is a water-soluble prodrug of combretastatin A4 (CA4).
The vascular targeting agent CA4 is a microtubule depolymerizing agent. The mechanism …

Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified
more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data …

There is increasing evidence that hypoxia-regulated gene expression influences tumor
aggressiveness, contributing to the poorer outcome of patients with hypoxic tumors. The role of …

Prostate cancer is a highly heritable disease with large disparities in incidence rates across
ancestry populations. We conducted a multiancestry meta-analysis of prostate cancer …

Affymetrix U133plus2 GeneChips were used to profile 59 head and neck squamous cell
cancers. A hypoxia metagene was obtained by analysis of genes whose in vivo expression …

BACKGROUND: Hypoxia is an important mechanism of treatment resistance in head and
neck squamous cell carcinoma (HNSCC). MicroRNAs are short noncoding RNAs that regulate …

The presence of hypoxia in tumours results in the overexpression of certain genes, which
are controlled via the transcription factor HIF‐1. Hypoxic cells are known to be radioresistant …

Purpose: Tumor hypoxia is associated with a poor prognosis, hypoxia modification improves
outcome, and hypoxic status predicts benefit from treatment. Yet, there is no universal …